Plasma hormone responses to tamoxifen therapy and oophorectomy.
The effect of tamoxifen therapy on plasma hormones in the pre- and postmenopausal state was studied in a young patient with breast cancer. Tamoxifen therapy was carried out for metastatic disease prior to (premenopausal) and after oophorectomy (surgical menopause). Changes in luteinizing hormone, follicle-stimulating hormone, prolactin, and estrogen were noted and were corroborated with the therapy or oophorectomy. The findings support some of the previously reported changes in those hormones that were noted in conjunction with tamoxifen therapy.
D000328:Adult; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000097:blood / Q000188:drug therapy* / Q000601:surgery; D002369:Castration; D004967:Estrogens / Q000097:blood; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D009362:Neoplasm Metastasis
D004967:Estrogens; D006065:Gonadotropins, Pituitary